Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TCR2 THERAPEUTICS INC.

(TCRR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on TCR2 THERAPEUTICS INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) TCR2 THERAPEUTICS INC.
Analyst Recommendations on TCR2 THERAPEUTICS INC.
10/21TCR2 THERAPEUTICS : Wedbush Trims Price Target for TCR2 Therapeutics to $10 From $11, Maintains Neutral Rating
MT
10/21TCR2 THERAPEUTICS : SVB Leerink Downgrades TCR2 Therapeutics to Market Perform from Outperform, Adjusts Price ..
MT
09/20TCR2 THERAPEUTICS : HC Wainwright Adjusts TCR2 Therapeutics' Price Target to $25 from $37, Keeps Buy Rating
MT
09/20TCR2 THERAPEUTICS : Truist Securities Adjusts Price Target on TCR2 Therapeutics to $29 From $40, Maintains Buy..
MT
09/17TCR2 THERAPEUTICS : Wedbush Moves to the Sidelines and Downgrades TCR2 Therapeutics to Neutral From Outperform..
MT
08/06TCR2 THERAPEUTICS : SVB Leerink Adjusts TCR2 Therapeutics' Price Target to $31 from $34, Keeps Outperform Rati..
MT
06/24TCR2 THERAPEUTICS : Goldman Sachs Starts TCR2 Therapeutics at Buy With $30 Price Target
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 5,01 $
Average target price 24,90 $
Spread / Average Target 397%
High Price Target 42,00 $
Spread / Highest target 738%
Low Price Target 7,00 $
Spread / Lowest Target 39,7%
Consensus detail
Consensus revision (last 18 months)